In vitro antibacterial activity of AM-715, a new nalidixic acid analog - Wikidata - wikimedia - TriplyDB

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

http://www.wikidata.org/entity/Q34709856

about

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin In vitro and in vivo activity of DL-8280, a new oxazine derivative In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone Chemotherapeutics A review of clinical trials with fluoroquinolones with an emphasis on new agents.Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.Purification of Citrobacter freundii DNA gyrase and inhibition by quinolones Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.In vitro activity of DR-3355, an optically active ofloxacin In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).Activities of new quinoline derivatives against genital pathogens.Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors.In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa.Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys.Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715)In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone.In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative.In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent.Comparative activities of eight quinolones against members of the Bacteroides fragilis group.Prediction of brain delivery of ofloxacin, a new quinolone, in the human from animal data.Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone.Lytic effect of two fluoroquinolones, ofloxacin and pefloxacin, on Escherichia coli W7 and its consequences on peptidoglycan composition.A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.Norfloxacin: clinical pharmacology and clinical use.In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone

P2860

Q24670241-C9262F2D-8539-4124-9371-E1C7E5BDC2C2 Q24671010-4B8AECAD-705E-4D30-A317-58B12B44C35B Q24674890-E77963C0-0C0C-44C3-9F4C-055C6635A8F4 Q24677059-5B54BA28-0686-4900-BDC5-4523CB0C9F45 Q24685742-96FA55EA-6C9D-404B-97B8-B4091F3447F9 Q28326997-95973A79-D46A-444D-855C-C7E6B5EDB905 Q30047670-E51EDD00-1ACA-4D74-9010-4CEE58843BA6 Q34074724-0B707122-8C7D-40CF-B7EE-D8B81CE328DC Q34250608-01C47854-73B9-48E9-8144-149189FF3575 Q34681603-AFAF2B51-F351-4885-BE1B-EAB2F84E2DB1 Q34707922-0AF7D936-5494-47F6-9817-00FB30696157 Q35289324-FE5B07E8-91F8-466B-9F6B-837811B44C82 Q35303163-19B48A98-0748-4058-A768-DF1FB2637261 Q35319641-FED33078-40AD-496B-834B-A0821341FB44 Q35340351-F28A3FB7-4660-4FDE-A1FE-12EEC8D1DC7A Q35354313-93C108A3-76BF-43F4-8646-CAA61DB0FF59 Q35563775-D00E40CC-6D7A-4B5E-AE44-49152AC39619 Q35568734-41F024B6-EFC3-4154-85EC-57C03A8AF201 Q35568919-EB81DD0F-3C74-4AC7-8419-6D560B3455CF Q35570242-21C83E06-AB78-4C2C-9C85-D52142A0C6B3 Q35572772-4A22B175-1493-4B7F-9540-E74283DB9EA4 Q35573087-7148B4AA-C5B4-483E-93EE-F18D80BFBD4F Q35646442-60BFABF8-46F3-4E3C-B4AC-EA812388D356 Q35648233-8730C633-B462-4A86-B804-FC910229F42F Q35671269-516D9196-E7BE-4521-9849-A6E958C7F890 Q35739778-8E134EE9-ACFE-4C2B-82C0-64486279A613 Q35742478-737FCB49-5061-4D69-BFDF-E0E56B2792EB Q35748588-2686B725-4DC2-4C24-B0FD-2B86654EF4C7 Q35757560-3EB0E3B4-30F8-4CE0-A362-4A851A769222 Q35769755-531B3CB3-AF51-4EDE-8026-267E119A5536 Q35809233-3BFFF9DB-E9B4-452A-A59A-F14D73699546 Q35809707-BA9C0368-14DB-4277-A05F-F69ACCDC7756 Q35812502-BD3F258E-8E7F-4C7D-B557-D33B68120B99 Q35821986-1FC04CF1-5235-43E0-B85A-B0E4E89DB5E9 Q36718935-E101D73B-6327-4687-BBC5-968716CE0F85 Q36753700-6DCDF0C7-6A61-41D6-9CFB-0D1827765F7F Q36754157-6B9463A0-D5E4-43DF-A0A1-4B9590544691 Q37204002-5045888F-411A-4893-963E-2A5873CDC6C4 Q39681144-3819A802-9FC6-4529-BE66-6A699613A59C Q39782054-20FC136E-C792-4104-BE89-9B1033C8D181

P2860

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

http://www.wikidata.org/entity/Q34709856

description

1980 nî lūn-bûn

@nan

1980 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1980 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1980年の論文

@ja

1980年論文

@yue

1980年論文

@zh-hant

1980年論文

@zh-hk

1980年論文

@zh-mo

1980年論文

@zh-tw

1980年论文

@wuu

name

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

@ast

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

@en

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

@nl

type

label

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

@ast

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

@en

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

@nl

prefLabel

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

@ast

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

@en

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

@nl

P1433

Q34709856-AF0B4746-C081-4C55-93C3-867DA530B359

P1476

Q34709856-3F25BEB8-F99F-4B6B-92A0-3D2FAB1A9EBE

P2093

Q34709856-041987F7-8FFD-4F57-AF2C-73F0EEB90971

Q34709856-07075902-891A-4605-A68B-029400B7C9C7

Q34709856-31D14EA9-45F6-4A86-9F9E-03E06824B57D

Q34709856-34B69E36-C2A4-458B-93C3-DFE59F277FC4

Q34709856-5290145B-DA2D-4C25-A3CD-839697B9A330

Q34709856-9A05F150-7E5B-4EC0-B995-2E34D9A71C41

Q34709856-D48C3289-2083-4161-BC80-34B7F85FD090

P2860

Q34709856-081147DF-BC2B-4015-8158-14562ADC8904

Q34709856-206E8970-EA1F-4022-8A36-283959BA9ADB

Q34709856-43FEF663-6596-4FC9-A424-8AA854542136

Q34709856-6EEEEAA7-0297-490D-A3E4-90355F0CF547

Q34709856-76CEDA7E-6918-4982-8058-9378169EC699

Q34709856-80532B70-85C2-4E11-BFAB-52951BC2D0A4

Q34709856-A8791483-A81C-4579-8BB7-012D619C162D

Q34709856-BD8271E1-ECEB-4AC9-996C-C6E2C686EF29

Q34709856-D5EC727B-C56B-4DA0-9A69-5A67B4579008

Q34709856-E10FDD16-43F9-4A7C-BC5D-F4A9B5DF5AF9

P304

Q34709856-27078096-A70D-424A-8FFA-2C91ED360DA4

P31

Q34709856-DFBAF62A-80D2-4682-A54A-F4FAE9FD7D81

P356

Q34709856-9AAC87F1-F5EC-42F7-BD7F-BD8BCAFB35B3

P407

Q34709856-A595B591-809F-448F-8507-85ED7F889820

P433

Q34709856-31A8A41A-4777-477E-962A-47F1A656FDF9

P478

Q34709856-1E22524A-D7CE-4FC0-ADBD-B49FB7631B93

P577

Q34709856-C58A8B54-8E72-42F9-B25F-A8B8B251BEBC

P698

Q34709856-233C7BAA-0CAD-480C-B3C2-39D6055DCEA0

P932

Q34709856-0C83EF31-D123-4D80-B050-082B096415EA

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

@en

P2093

Hirai K

http://www.w3.org/2001/XMLSchema#string

Inoue M

http://www.w3.org/2001/XMLSchema#string

Irikura T

http://www.w3.org/2001/XMLSchema#string

Ito A

http://www.w3.org/2001/XMLSchema#string

Koga H

http://www.w3.org/2001/XMLSchema#string

Mitsuhashi S

http://www.w3.org/2001/XMLSchema#string

Suzue S

http://www.w3.org/2001/XMLSchema#string

P2860

Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids

Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins

Pipemidic acid: its activities against various experimental infections.

Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates.

Determination of the ID50 values of antibacterial agents in agar.

1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.

Pyrido(2,3-d)pyrimidine antibacterial agents. 3. 8-Alkyl- and 8-vinyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-carboxylic acids and their derivatives.

Changing ecology of bacterial infections as related to antibacterial therapy.

Changing patterns in surgical infections.

Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria.

P304

103-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.17.2.103

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

1980-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6446258

http://www.w3.org/2001/XMLSchema#string

P932

283741

http://www.w3.org/2001/XMLSchema#string